Background Afterload reduction decreases volume overload on the left ventri
cle and may thereby delay the need for valve replacement in chronic asympto
matic aortic regurgitation. The aims of this randomized double-blind, place
bo-controlled trial were to examine short- and long-term hemodynamic effect
s of felodipine in chronic asymptomatic aortic regurgitation.
Methods sixteen patients were randomly assigned to an intravenous infusion
of either felodipine 0.3 mg or placebo Followed by 3 months' treatment with
felodipine 10 mg or placebo orally once daily. Magnetic resonance imaging
was performed at baseline, immediately after intravenous treatment, and aft
er 3 months of oral treatment.
Results Intravenous felodipine caused a statistically significant reduction
in the systemic vascular resistance from (mean +/- SD) 1160 +/- 400 to 970
+/- 320 dynes . s . cm(-5) (P < .05), in the regurgitant volume index from
1.5 +/- 0.8 to 1.3 +/- 0.8 L . min(-1) m(-2) (P < .05), and in the regurgi
tant fraction from 0.31 +/- 0.15 to 0.26 +/- 0.14 (P < .05). The forward ca
rdiac output index increased significantly from 3.2 +/- 0.9 to 3.5 +/- 0.7
L . min(-1) . m(-2) (P < .05). Three months of oral treatment with felodipi
ne caused a corresponding but more pronounced decrease in systemic vascular
resistance of 880 +/- 330 dynes . s . cm(-5) (P < .05), regurgitant volume
index of 1.2 +/- 0.7 L . min(-1) . m(-2) (P < .05), and regurgitant fracti
on 0.25 +/- 0.11 (P < .05), whereas the forward cardiac output index increa
sed to 3.6 +/- 0.7 L . min(-1) . m(-2) (P < .05). No significant changes we
re found in the placebo group. left ventricular volumes and election Fracti
on remained unaffected by treatment, but compared with the placebo group le
ft ventricular myocardial mass decreased significantly from 137 +/- 24 to 1
32 +/- 21 g . m(-2) (P < .01).
Conclusion In chronic asymptomatic aortic regurgitation, felodipine causes
beneficial hemodynamic effects that may postpone the need for valve replace
ment.